Возраст домена | 16 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | |
Страниц в Google | 376 |
Страниц в Яндексе | 151 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 1373818 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Home | Coriolis Pharma
n/a
n/a
UTF-8
78.71 КБ
856
7 737 симв.
6 678 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
41 | 9 |
0 | 5 | ![]() | |
![]() ![]() |
20 | 9 |
0 | 2 | ![]() | |
![]() ![]() |
20 | 8 |
0 | 113 | ![]() | |
![]() ![]() |
13 | 9 |
0 | 172 | ![]() | |
![]() |
13 | 5 |
0 | 38990 | ![]() | |
![]() ![]() |
11 | 8 |
0 | 1205 | ![]() | |
![]() |
9 | 4 |
10 | 1438389 | ![]() | |
![]() |
9 | 4 |
0 | 4349045 | ![]() |
|
![]() |
9 | n/a | 10 | 138396 | ![]() | |
![]() ![]() |
9 | 5 |
10 | 189790 | ![]() | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 19 Ноября 2016 ) | |
Количество ссылок на сайт | 15 |
Количество доменов, которые ссылаются на сайт | 14 |
Количество найденных анкоров | 8 |
Исходящие (внешние) ссылки домена | 58 |
Количество доменов, на которые ссылается сайт | 6 |
Количество исходящих анкоров | 6 |
Внутренние ссылки главной страницы ( 105 ) | |
#content_start | <div> |
/contact-us | Contact Us |
pickup.coriolis-pharma.com | Pickup Server |
/analytical-capabilities | Read more |
/formulation-development | Read more |
/about-us | Read more |
/particle-characterization | Particle Characterization – Overview |
/analytical-capabilities/particle-characterization/asymmetri... | Asymmetrical flow field-flow fractionation (AF4) |
/analytical-capabilities/particle-characterization/backgroun... | Backgrounded membrane imaging (BMI) |
/analytical-capabilities/particle-characterization/dynamic-l... | Dynamic Light Scattering (DLS) |
/analytical-capabilities/particle-characterization/electrica... | Electrical sensing zone (ESZ) / microfluidic resistive pulse sensing (MRPS) |
/analytical-capabilities/particle-characterization/micro-flo... | Micro-flow imaging (MFI) |
/fourier-transform-infrared-FTIR-microscopy | Fourier transform infrared (FTIR) microscopy |
/hollow-fiber-flow-field-flow-fractionation-hf5 | Hollow fiber flow field-flow fractionation (HF5) |
/imaging-flow-cytometry-ifc | Imaging flow cytometry (IFC) |
/light-microscopy-lm | Light microscopy (LM) |
/light-obscuration-lo | Light obscuration (LO) |
/nanoparticle-tracking-analysis-nta | Nanoparticle tracking analysis (NTA) |
/analytical-capabilities/aggregate-analytics/nephelometry-tu... | Nephelometry / Turbidity |
/analytical-capabilities/particle-characterization/quantitat... | Quantitative laser diffraction (qLD) |
/analytical-capabilities/particle-characterization/raman-mic... | Raman microscopy |
/analytical-capabilities/particle-characterization/resonant-... | Resonant mass measurement (RMM) |
/analytical-capabilities/particle-characterization/semi-auto... | Semi-automated visual inspection (SAVI) |
/analytical-capabilities/particle-characterization/transmiss... | Transmission electron microscopy (TEM) |
/analytical-capabilities/particle-characterization/visual-in... | Visual inspection |
/analytical-capabilities/aggregate-analytics | Aggregate analytics – Overview |
/analytical-capabilities/aggregate-analytics/analytical-ultr... | Analytical ultracentrifugation (AUC) |
/capillary-gel-electrophoresis-cge | Capillary gel electrophoresis (cGE) |
/high-performance-size-exclusion-chromatography-hp-sec | High performance size-exclusion chromatography (HP-SEC) |
/analytical-capabilities/aggregate-analytics/liquid-chromato... | Liquid chromatography coupled mass spectrometry (LC-MS) |
/analytical-capabilities/aggregate-analytics/sds-page | SDS-PAGE |
/analytical-capabilities/aggregate-analytics/ultra-high-perf... | Ultra-high-performance size-exclusion chromatography (UP-SEC) |
/analytical-capabilities/gmp-analytics | GMP Analytics |
/analytical-capabilities/gmp-analytics/analysis-polysorbate-... | Analysis of polysorbate in GMP compliance |
/analytical-capabilities/gmp-analytics/analysis-subvisible-p... | Analysis of subvisible particles and aggregates in GMP compliance |
/analytical-capabilities/surfactant-characterization | Surfactant characterization – Overview |
/analytical-capabilities/surfactant-characterization/liquid-... | Liquid chromatography with charged aerosol detection (LC-CAD) |
/analytical-capabilities/biosafety-level-1-2 | Biosafety level 1 / 2 |
/analytical-capabilities/higher-order-structure | Higher Order Structure – Overview |
/analytical-capabilities/higher-order-structure/circular-dic... | Circular dichroism (CD) |
/analytical-capabilities/higher-order-structure/differential... | Differential scanning calorimetry (µDSC) |
/analytical-capabilities/higher-order-structure/fluorescence... | Fluorescence spectroscopy |
/analytical-capabilities/higher-order-structure/fourier-tran... | Fourier transform infrared (FTIR) spectroscopy |
/analytical-capabilities/higher-order-structure/nano-differe... | Nano differential scanning fluorimetry (nanoDSF) |
/analytical-capabilities/chemical-changes | Chemical Changes – Overview |
/analytical-capabilities/chemical-changes/capillary-isoelect... | Capillary isoelectric focusing (cIEF) |
/analytical-capabilities/chemical-changes/ion-exchange-chrom... | Ion-exchange chromatography (IEX) |
/analytical-capabilities/chemical-changes/reversed-phase-chr... | Reversed-phase chromatography (RP-HPLC / RP-UPLC) |
/analytical-capabilities/applications | Applications |
/analytical-capabilities/additional-services | Additional Services – Overview |
/analytical-capabilities/additional-services/physico-chemica... | Physico-chemical characterization of lyophilizates |
/analytical-capabilities/additional-services/container-closu... | Container closure integrity testing |
/analytical-capabilities/additional-services/basic-formulati... | Basic formulation characterization |
/formulation-development/functional-assays | Functional assays |
/formulation-development/our-approach | Our Approach – Overview |
/formulation-development/our-approach/product-types | Product types |
/formulation-development/our-approach/high-throughput-screen... | High-throughput screening |
/formulation-development/our-approach/design-experiments-doe | Design of experiments (DoE) |
/formulation-development/liquid-formulations | Liquid formulations – Overview |
/formulation-development/liquid-formulations/liquid-versus-f... | Liquid versus frozen-liquid |
/formulation-development/liquid-formulations/low-concentrati... | Low-concentration versus high-concentration liquid formulation |
/formulation-development/liquid-formulations/formulation-rob... | Formulation robustness studies |
/formulation-development/lyophilized-formulations | Lyophilized formulations |
/formulation-development/stability-and-forced-degradation-st... | Stability and forced degradation studies – Overview |
/formulation-development/stability-and-forced-degradation-st... | ICH stability studies |
/formulation-development/stability-and-forced-degradation-st... | In-use stability |
/formulation-development/stability-and-forced-degradation-st... | Forced degradation studies |
/formulation-development/stability-and-forced-degradation-st... | Comparability studies |
/formulation-development/lyophilization-process-development | Lyophilization process development – Overview |
/formulation-development/lyophilization-process-development/... | Cycle design and optimization |
/formulation-development/lyophilization-process-development/... | Robustness testing, scale-up and transfer |
/formulation-development/lyophilization-process-development/... | Equipment |
/formulation-development/virus-based-advanced-therapy-medici... | Virus-based advanced therapy medicinal products (ATMPs) |
/formulation-development/supply-preclinical-material | Supply of Preclinical Material |
/formulation-development/developability-manufacturability | Developability / Manufacturability |
/about-us/management-team | Management team |
/about-us/scientific-advisory-board | Scientific advisory board |
/about-us/research-publications-coriolis | View all |
/about-us/working-coriolis | Working at Coriolis |
career.coriolis-pharma.com/ | Job vacancies |
/about-us/news-events | View all |
/about-us/vision | Vision |
/about-us/news-events/coriolis-spreads-christmas-spirit | 2019/12/20 Coriolis spreads the Christmas spirit Read more |
/about-us/news-events/coriolis-scientific-advisor-give-keyno... | 2019/11/15 Coriolis scientific advisor to give Keynote Presentation at PEGS Europe Read more |
/about-us/news-events/coriolis-co-organizes-workshop-protein... | 2019/11/13 Coriolis co-organizes workshop on protein stability Read more |
/about-us/news-events/coriolis-scientific-advisor-speaks-mib... | 2019/11/11 Coriolis scientific advisor speaks at MIBio in Cambridge, UK Read more |
/about-us/news-events/engage-coriolis-partnering-event-hambu... | 2019/11/05 Engage with Coriolis at Partnering Event in Hamburg Read more |
/about-us/news-events/speed-date-coriolis-tum-career-days | 2019/11/05 Speed-Date Coriolis at the TUM Career Days Read more |
/about-us/news-events/coriolis-participates-three-talks-aaps... | 2019/10/18 Coriolis participates with three talks at AAPS PharmSci 360 event Read more |
/about-us/news-events/coriolis-cso-will-talk-pda-workshop-sw... | 2019/10/14 Coriolis CSO will talk at PDA workshop in Sweden Read more |
/about-us/news-events/get-know-us-inpharma-symposium-munich | 2019/10/07 Get to know us at the InPharma Symposium in Munich Read more |
/about-us/news-events/coriolis-will-be-present-pda-europe-ev... | 2019/09/20 Coriolis will be present at PDA Europe event in Berlin Read more |
/node/330 | Taking subvisible particle quantitation to the limit: Uncertainties and statistical challenges with ophthalmic products for intr... |
/node/331 | Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life ... |
/node/329 | Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative Degradation. Kranz W, Wuchner K,... |
/node/323 | Intrinsic Differential Scanning Fluorimetry for Fast and Easy Identification of AAV Serotypes. Rieser R, Penaud-Budloo M,... |
/node/320 | Novel high-throughput assay for polysorbate quantification in biopharmaceutical products by using the fluorescent dye DiI. ... |
/node/321 | What makes polysorbate functional? Impact of polysorbate 80 grade and quality on IgG stability during mechanical stress. ... |
/node/319 | Stress Factors in Monoclonal Antibody Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and ... |
/node/316 | Shifting Paradigms Revisited: Biotechnology and the Pharmaceutical Sciences Crommelin D, Nastribattusta E, Hawe A, Hoogen... |
/node/290 | Immunogenicity of therapeutic proteins. Jiskoot W, Rispens T and Kijanka G. Read more |
/node/288 | Biophysical and biochemical characteristics of therapeutic proteins. Jiskoot W and Crommelin DJA. Read more |
/disclaimer | Disclaimer |
/data-privacy | Data Privacy |
/imprint | Imprint |
Domain Name: CORIOLIS-PHARMA.COM
Registry Domain ID: 1391439467_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.1and1.com
Registrar URL: http://registrar.1and1.info
Updated Date: 2018-03-07T09:24:43Z
Creation Date: 2008-01-31T02:40:04Z
Registry Expiry Date: 2019-01-31T02:40:04Z
Registrar: 1&1 Internet SE
Registrar IANA ID: 83
Registrar Abuse Contact Email: abuse@1and1.com
Registrar Abuse Contact Phone: +1.6105601459
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1096.UI-DNS.BIZ
Name Server: NS1096.UI-DNS.COM
Name Server: NS1096.UI-DNS.DE
Name Server: NS1096.UI-DNS.ORG
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-08-01T16:54:53Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used: http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html
User-agent: *
Sitemap: http://www.coriolis-pharma.com/sitemap.xml
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files
Disallow: /README.txt
Disallow: /web.config
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register/
Disallow: /user/password/
Disallow: /user/login/
Disallow: /user/logout/
# Paths (no clean URLs)
Disallow: /index.php/admin/
Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips
Disallow: /index.php/node/add/
Disallow: /index.php/search/
Disallow: /index.php/user/password/
Disallow: /index.php/user/register/
Disallow: /index.php/user/login/
Disallow: /index.php/user/logout/
Франция - Lanquetot - 194.2.116.17
Orange
Orange
HTTP/1.1 200 OK
Date: Wed, 08 Jan 2020 23:36:14 GMT
Server: Apache/2.4.25 (Debian) OpenSSL/1.0.2r
Cache-Control: must-revalidate, no-cache, private
X-Drupal-Dynamic-Cache: MISS
Link: ; rel="canonical"
Link: ; rel="shortlink"
Link: ; rel="revision"
X-UA-Compatible: IE=edge
Content-language: en
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Vary: Accept-Encoding
X-Generator: Drupal 8 (https://www.drupal.org)
X-Drupal-Cache: HIT
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"